GeneDx Holdings Corp.WGSNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank43
5Y CAGR-43.9%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

5Y CAGR
-43.9%/yr
Long-term compound
Percentile
P43
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q4 20253.64%
Q3 202513.68%
Q2 202517.88%
Q1 2025-8.91%
Q4 202424.41%
Q3 20249.02%
Q2 202412.96%
Q1 20248.72%
Q4 20237.72%
Q3 20239.44%
Q2 202312.90%
Q1 2023-29.68%
Q4 2022-26.29%
Q3 2022130.13%
Q2 2022-32.95%
Q1 2022-6.68%
Q4 202133.87%
Q3 2021-8.16%
Q2 2021-26.77%
Q1 20210.38%
Q4 202065.66%
Q3 20200.00%